The efficacy and safety of tranexamic acid for reducing blood loss following simultaneous bilateral total knee arthroplasty: a multicenter retrospective study
Tóm tắt
The purpose of the study was to evaluate whether tranexamic acid (TXA) administration could reduce blood loss and transfusion risk after simultaneous bilateral total knee arthroplasty (SBTKA). As a multicenter retrospective study, a total of 575 patients were assigned into three groups on the basis of TXA usage, including intravenous (IV) group (1 g IV TXA 5–10 min prior to the incision), combined group (1 g IV TXA combined with intra-articular injection of 1 g TXA prior to the closure every knee) and control group (no TXA use). The primary outcomes were total blood loss (TBL). The secondary outcomes were maximum hemoglobin (Hb) and hematocrit (Hct) drop, transfusion rate, drain volume, length of stay, hospitalization expenses and the incidence of complications. The mean TBL in control group (1685.0 ± 571.4 mL) were higher than that in IV group (1061.1 ± 689.6 mL, p = 0.006 and combined group (988.3 ± 559.3 mL, p = 0.003). The maximum Hb and Hct drop in combined group (28.5 ± 13.4 g/L, p = 0.016; 0.074 ± 0.053, p < 0.001) and IV group (28.8 ± 14.5 g/L, p = 0.025; 0.082 ± 0.056, p = 0.001) were lower than those in control group (33.4 ± 14.0; 0.131 ± 0.049). But the difference between IV and combined groups was not significant. The similar trend was detected on drain volume, length of stay and hospitalization expenses. The incidence of complications did not differ significantly among the three groups (p > 0.05). The study indicates that TXA could reduce blood loss with no apparent increase in the incidence of complications during SBTKA.
Tài liệu tham khảo
Blajchman MA, Beckers EA, Dickmeiss E, Lin L, Moore G, Muylle L. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev. 2005;19(4):259–72.
Fuller AK, Uglik KM, Savage WJ, Ness PM, King KE. Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion. 2009;49(12):2588–93.
Hogan CA, Golightly LK, Phong S, Dayton MR, Lyda C, Barber GR. Perioperative blood loss in total hip and knee arthroplasty: outcomes associated with intravenous tranexamic acid use in an academic medical center. SAGE Open Med. 2016;4:2050312116637024.
Sassoon A, Nam D, Jackups R, Johnson SR, Nunley RM, Barrack RL. Tranexamic acid: optimal blood loss management in surface replacement arthroplasty. Bone Joint J. 2016;98-b(2):173–8.
Bagsby DT, Samujh CA, Vissing JL, Empson JA, Pomeroy DL, Malkani AL. Tranexamic acid decreases incidence of blood transfusion in simultaneous bilateral Total knee arthroplasty. J Arthroplast. 2015;30(12):2106–9.
Chen X, Cao X, Yang C, Guo K, Zhu Q, Zhu J. Effectiveness and safety of fixed-dose tranexamic acid in simultaneous bilateral Total knee arthroplasty: a randomized double-blind controlled trial. J Arthroplast. 2016;31(11):2471–5.
Prieto HA, Vincent HK, Deen JT, Iams DA, Parvataneni HK. Tranexamic acid effectively reduces blood loss and transfusion rates during simultaneous bilateral Total knee arthroplasty. J Knee Surg. 2018;31(3):270–6.
Suh DW, Han SB, Park JH, Cheong K, Kyung BS. Intravenous iron supplementation with intra-articular administration of tranexamic acid reduces the rate of allogeneic transfusions after simultaneous bilateral total knee arthroplasty. Blood Transfus. 2017;15(6):506–11.
Cao G, Huang Z, Huang Q, Zhang S, Xu B, Pei F. Incidence and risk factors for blood transfusion in simultaneous bilateral Total joint arthroplasty: a multicenter retrospective study. J Arthroplast. 2018;33(7):2087–91.
Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58(3):277–80.
Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–32.
Liu X, Zhang X, Chen Y, Wang Q, Jiang Y, Zeng B. Hidden blood loss after total hip arthroplasty. J Arthroplast. 2011;26(7):1100–1105.e1101.
Bedard NA, Pugely AJ, Lux NR, Liu SS, Gao Y, Callaghan JJ. Recent trends in blood utilization after primary hip and knee arthroplasty. J Arthroplast. 2017;32(3):724–7.
Parvizi J, Chaudhry S, Rasouli MR, Pulido L, Joshi A, Herman JH, Rothman RH. Who needs autologous blood donation in joint replacement? J Knee Surg. 2011;24(1):25–31.
Karaaslan F, Karaoglu S, Mermerkaya MU, Baktir A. Reducing blood loss in simultaneous bilateral total knee arthroplasty: combined intravenous-intra-articular tranexamic acid administration. A prospective randomized controlled trial. Knee. 2015;22(2):131–5.
Karam JA, Bloomfield MR, DiIorio TM, Irizarry AM, Sharkey PF. Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. J Arthroplast. 2014;29(3):501–3.
Cao G, Xie J, Huang Z, Huang Q, Chen G, Lei Y, Xu H, Pei F. Efficacy and safety of multiple boluses of oral versus intravenous tranexamic acid at reducing blood loss after primary total knee arthroplasty without a tourniquet: a prospective randomized clinical trial. Thromb Res. 2018;171:68–73.
Lei Y, Xie J, Xu B, Xie X, Huang Q, Pei F. The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial. Int Orthop. 2017;41(10):2053–9.
Xiong H, Liu Y, Zeng Y, Wu Y, Shen B. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2018;19(1):321.
MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplast. 2011;26(1):24–8.
Liodakis E, Antoniou J, Zukor DJ, Huk OL, Epure LM, Bergeron SG. Navigated vs conventional Total knee arthroplasty: is there a difference in the rate of respiratory complications and transfusions? J Arthroplast. 2016;31(10):2273–7.